About OJO | Search | Ahead of print | Current Issue | Archives | Author Instructions | Reviewer Guidelines | Online submissionLogin 
Oman Journal of Ophthalmology Oman Journal of Ophthalmology
  Editorial Board | Subscribe | Advertise | Contact
https://www.omanophthalmicsociety.org/ Users Online: 355  Wide layoutNarrow layoutFull screen layout Home Print this page  Email this page Small font size Default font size Increase font size


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2013  |  Volume : 6  |  Issue : 1  |  Page : 65-66  

Nodular episcleritis after laser in situ keratomileusis in patient with systemic lupus erythematosus


Anterior Segment Division, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia

Date of Web Publication15-May-2013

Correspondence Address:
Mohammad Al-Amry
Anterior Segment Division, King Khaled Eye Specialist Hospital, P.O. Box 7191, Riyadh - 11462
Kingdom of Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-620X.111938

Rights and Permissions

How to cite this article:
Al-Amry M. Nodular episcleritis after laser in situ keratomileusis in patient with systemic lupus erythematosus. Oman J Ophthalmol 2013;6:65-6

How to cite this URL:
Al-Amry M. Nodular episcleritis after laser in situ keratomileusis in patient with systemic lupus erythematosus. Oman J Ophthalmol [serial online] 2013 [cited 2019 Dec 14];6:65-6. Available from: http://www.ojoonline.org/text.asp?2013/6/1/65/111938

Sir,

Laser in situ keratomileusis (LASIK) is safe and efficacious for the treatment of refractive error. However, controversy remains regarding LASIK for patients with autoimmune disorders. [1],[2],[3] Episcleritis is a manifestation of systemic lupus erythematosis (SLE), which can be successfully managed by observation and topical lubricants. However, some cases may warrant the use of topical corticosteroids.

A 28-year-old female with an established well controlled SLE underwent uneventful bilateral LASIK for myopic astigmatism. A mechanical microkeratome was used to perform the keratectomy. One week post-operatively the patient presented with tearing, moderate pain, and redness in the lateral aspect of her left eye. On examination, her vision was 20/20 and the Slit lamp examination indicated a nodular episcleritis surrounded by engorged episcleral blood vessels [Figure 1]. The posterior segment examination was unremarkable.
Figure 1: Nodular episcleritis 1 week after laser in situ keratomileusis in a patient with well controlled systemic lupus erythematosus

Click here to view


Topical prednisolone acetate 1%, and diclofenac sodium 1%, 4 times a day was started. The episcleritis was completely resolved within 2 weeks and the patient has remained free of systemic or ocular reactivation over the last 3 years [Figure 2].
Figure 2: Complete resolution of episcleritis after topical corticosteroid therapy in a patient with well controlled systemic lupus erythematosus who had undergone laser in situ keratomileusis

Click here to view


Ophthalmic manifestations occur through immune vasculitis and/or thrombosis and immune complex deposition with wide range of clinical presentation including, scleritis and episcleritis. [4] Episcleritis is an acute self-limited inflammation of the episclera that frequently affects young and middle aged individuals. It occurs in association with SLE in one-third of the cases. [4]

SLE is a chronic, systemic autoimmune disease, occur 9 times more frequently in typically young, middle-aged women. Some have postulated that estrogens enhance the immune response. [5]

LASIK is suitable in well controlled autoimmune disorders such as SLE. Smith and Maloney [1] performed LASIK in 49 eyes of 26 patients with autoimmune diseases, 7 of whom had SLE and reported no complications. We recommend judicious use of topical steroids in cases of episcleritis due to the attendant risks of steroid use. SLE patients have an altered autoimmune system. Even when they are symptom-free, the disease may not be inactive; this makes them susceptible to the risk of post-operative inflammation. This possibility should be explained to the patient pre-operatively.

 
   References Top

1.Smith RJ, Maloney RK. Laser in situ keratomileusis in patients with autoimmune diseases. J Cataract Refract Surg 2006;32:1292-5.  Back to cited text no. 1
    
2.Kohnen T. Excimer laser refractive surgery in autoimmune diseases. J Cataract Refract Surg 2006;32:1241.  Back to cited text no. 2
    
3.Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 2007;46:1757-62.  Back to cited text no. 3
    
4.Akpek EK, Uy HS, Christen W, Gurdal C, Foster CS. Severity of episcleritis and systemic disease association. Ophthalmology 1999;106:729-31.  Back to cited text no. 4
    
5.Read RW, Weiss AH, Sherry DD. Episcleritis in childhood. Ophthalmology 1999;106:2377-9.  Back to cited text no. 5
    


    Figures

  [Figure 1], [Figure 2]



 

Top
   
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References
    Article Figures

 Article Access Statistics
    Viewed2036    
    Printed34    
    Emailed0    
    PDF Downloaded166    
    Comments [Add]    

Recommend this journal